About Tigermed

Our Company

Culture & Values

Leadership

Global Locations

Corporate Compliance

Subsidiaries & Joint Ventures

Diversity & Inclusion

20th Anniversary

Media & Resources

Press Releases

Events

Tigermed Insights

Resource Library

Cloud Classroom

Environment, Social and Governance (ESG)

Sustainability & ESG Report

ESG Management

Corporate Responsibility

Corporate Video

We are committed to supporting our clients in their clinical development in the best possible way.

By Phase

Preclinical

Early Phase

Phase II-III Clinical

Post-Marketing

Real World Study

Preclinical Development

Medicinal Chemistry

Compound Screening

DMPK

Safety & Toxicology

Bioanalytical

CMC

Clinical Development

Medical Writing

Clinical Monitoring

Regulatory Affairs

Data Management and Statistical Analysis

Clinical Development Strategy

Decentralized Clinical Trials (DCTs)

Site Management (SMO)

Medical Device / IVD

Multi-region Clinical Trial (MRCT)

Vaccine Clinical Trial

Integrated Capabilities

Medical Imaging

Pharmacovigilance

Medical Translation

Quality Assurance

GMP Consulting

Central Laboratories

Functional Service Provider (FSP)

Recruitment Management

EDC System

Remote Follow-up Center

Therapeutic Expertise

GLP-1 RA

Cell and Gene Therapy

Radiopharmaceutical

Oncology

Infectious Diseases

Hematology

Cardiovascular

Endocrinology

Rheumatology

Central Nervous System

Gastroenterology

Ophthalmology

Careers

Talent Development

Enjoy Your Life with Tigermed

Join Tigermed (China)

Join Tigermed (Global)

Global Locations

Discover our offices across Asia, US, Europe, Latin America and Africa.

Career Opportunities

Explore your career opportunities worldwide with Tigermed.

Investors

Corporate Governance

Financial Reports and Presentations

Announcements

Prospectus

Investor Contact

Tigermed 2025 Interim Results Presentation

View Tigermed 2025 Interim Results Presentation

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025

Contact

Business Enquiry / RFP

Client Service Center

Media & Investors Enquiry

Compliance Concern

Business Enquiry / RFP

Email: marketing@tigermedgrp.com

Client Service Center

Email:clientservice@tigermedgrp.com

Media & Investors Enquiry

Email:PR@tigermedgrp.com

Compliance Concern

Email: compliance.officer@tigermedgrp.com

QUICK LINKS

  • Preclinical
  • Early Phase
  • Phase II-III Clinical
  • Post-Marketing
  • Real World Study
EN
简 繁
    • Our Company
    • Culture & Values
    • Leadership
    • Global Locations
    • Corporate Compliance
    • Subsidiaries & Joint Ventures
    • Diversity & Inclusion
    • 20th Anniversary
    • Press Releases
    • Events
    • Tigermed Insights
    • Resource Library
    • Cloud Classroom
    • Sustainability & ESG Report
    • ESG Management
    • Corporate Responsibility
    • Preclinical
    • Early Phase
    • Phase II-III Clinical
    • Post-Marketing
    • Real World Study
    • Medicinal Chemistry
    • Compound Screening
    • DMPK
    • Safety & Toxicology
    • Bioanalytical
    • CMC
    • Medical Writing
    • Clinical Monitoring
    • Regulatory Affairs
    • Data Management and Statistical Analysis
    • Clinical Development Strategy
    • Decentralized Clinical Trials (DCTs)
    • Site Management (SMO)
    • Medical Device / IVD
    • Multi-region Clinical Trial (MRCT)
    • Vaccine Clinical Trial
    • Medical Imaging
    • Pharmacovigilance
    • Medical Translation
    • Quality Assurance
    • GMP Consulting
    • Central Laboratories
    • Functional Service Provider (FSP)
    • Recruitment Management
    • EDC System
    • Remote Follow-up Center
    • GLP-1 RA
    • Cell and Gene Therapy
    • Radiopharmaceutical
    • Oncology
    • Infectious Diseases
    • Hematology
    • Cardiovascular
    • Endocrinology
    • Rheumatology
    • Central Nervous System
    • Gastroenterology
    • Ophthalmology
  • Talent Development
  • Enjoy Your Life with Tigermed
  • Join Tigermed (China)
  • Join Tigermed (Global)
  • Corporate Governance
  • Financial Reports and Presentations
  • Announcements
  • Prospectus
  • Investor Contact
  • Business Enquiry / RFP
  • Client Service Center
  • Media & Investors Enquiry
  • Compliance Concern
Tigermed Logo - Contract Research Organization (CRO)
About Solutions Careers Investors Contact
简 繁

Investors

Announcements

  1. Home
  2. Investors

  3. Announcements

  • Aug 28, 2025

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025

    Read more

  • Aug 28, 2025

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025

    Read more

  • Aug 18, 2025

    DATE OF BOARD MEETING

    Read more

  • Aug 18, 2025

    DATE OF BOARD MEETING

    Read more

  • Aug 05, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025

    Read more

  • Aug 05, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025

    Read more

  • Jul 28, 2025

    VOLUNTARY ANNOUNCEMENT - Acquisition of partial equity interest in MICRON in Japan by a wholly-owned subsidiary

    Read more

  • Jul 28, 2025

    VOLUNTARY ANNOUNCEMENT - Acquisition of partial equity interest in MICRON in Japan by a wholly-owned subsidiary

    Read more

  • Jul 04, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025

    Read more

  • Jul 04, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025

    Read more

  • Jun 19, 2025

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024 (UPDATED)

    Read more

  • Jun 19, 2025

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024 (UPDATED)

    Read more

  • Jun 19, 2025

    CHANGE OF PAYMENT DATE OF FINAL DIVIDEND OF H SHARES

    Read more

  • Jun 19, 2025

    CHANGE OF PAYMENT DATE OF FINAL DIVIDEND OF H SHARES

    Read more

  • Jun 03, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025

    Read more

  • Jun 03, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025

    Read more

  • May 30, 2025

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024 (UPDATED)

    Read more

  • May 30, 2025

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024 (UPDATED)

    Read more

  • May 30, 2025

    ARTICLES OF ASSOCIATION

    Read more

  • May 30, 2025

    ARTICLES OF ASSOCIATION

    Read more

  • May 30, 2025

    POLL VOTING RESULTS OF THE 2024 ANNUAL GENERAL MEETING, THE 2025 FIRST A SHARE CLASS MEETING AND THE 2025 FIRST H SHARE CLASS MEETING HELD ON MAY 30, 2025

    Read more

  • May 30, 2025

    POLL VOTING RESULTS OF THE 2024 ANNUAL GENERAL MEETING, THE 2025 FIRST A SHARE CLASS MEETING AND THE 2025 FIRST H SHARE CLASS MEETING HELD ON MAY 30, 2025

    Read more

  • Apr 30, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025

    Read more

  • Apr 30, 2025

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025

    Read more

  • Apr 29, 2025

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024 (UPDATED)

    Read more

  • Apr 29, 2025

    FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024 (UPDATED)

    Read more

  • Apr 29, 2025

    Form of Proxy for the 2024 Annual General Meeting to be held on Friday, May 30, 2025

    Read more

  • Apr 29, 2025

    Form of Proxy for the 2024 Annual General Meeting to be held on Friday, May 30, 2025

    Read more

  • Apr 29, 2025

    Form of Proxy for the 2025 First H Share Class Meeting to be held on Friday, May 30, 2025

    Read more

  • Apr 29, 2025

    Form of Proxy for the 2025 First H Share Class Meeting to be held on Friday, May 30, 2025

    Read more



Previous Next
1 2 3 4 5 6 7 8 9 10 ... 24 25


  • About Tigermed
  • Environment, ESG
  • Media and Resources
  • By Phase
  • Preclinical Development
  • Clinical Development
  • Integrated Capabilities
  • Therapeutic Expertise
  • Talent Development
  • Enjoy Your Life with Tigermed
  • Join Tigermed
  • Corporate Governance
  • Financial Reports and Presentations
  • Announcements
  • Prospectus
  • Investor Contact
  • Business Enquiry / RFP
  • Client Service Center
  • Media & Investors Enquiry
  • Compliance Concern

Footer

About

  • Our Company
  • Leadership
  • Global Locations
  • Press Releases
  • Events

Solutions

  • Preclinical
  • Early Phase
  • Phase II-III Clinical
  • Post-Marketing
  • Real World Study

Careers

  • Talent Development
  • Enjoy Your Life with Tigermed
  • Join Tigermed

Investors

  • Corporate Governance
  • Financial Reports and Presentations
  • Announcements
  • Prospectus
  • Investor Contact

Contact

  • Business Enquiry / RFP
  • Client Service Center
  • Media & Investors Enquiry
  • Compliance Concern

Global Headquarters

F 18, Building A – Shengda Science Park, No.19 Jugong Road, Binjiang District, Hangzhou, China 310051

Tel: +86-571-28887227

Copyright © 2004- Tigermed All Rights Reserved. 浙ICP备11043991号-7

Cookies Privacy Policy Terms of Use
Cookies

The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.

Contact us
Business Enquiry / RFP
Client Service Center
Media & Investors Enquiry
Compliance Concern